PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome.

Abstract Neonatal abstinence syndrome (NAS) is a drug withdrawal syndrome that most commonly occurs in infants after in utero exposure to opioids, although other substances have also been associated with the syndrome (1). NAS usually appears within 48-72 hours of birth with a constellation of clinical signs, including central nervous system irritability (e.g., tremors), gastrointestinal dysfunction (e.g., feeding difficulties), and temperature instability (1) (Box 1). Opioid exposure during pregnancy might result from clinician-approved use of prescription opioids for pain relief; misuse or abuse of prescription opioids; illicit use (e.g., heroin); or medication-assisted treatment (MAT) of opioid use disorder (2) (Box 2).
PMID
Related Publications

Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013.

The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment.

Opioids in pregnancy and neonatal abstinence syndrome.

Implementation of a statewide surveillance system for neonatal abstinence syndrome - Tennessee, 2013.

Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.

Authors

Mayor MeshTerms

Public Health Practice

Keywords
Journal Title mmwr. morbidity and mortality weekly report
Publication Year Start




PMID- 28278146
OWN - NLM
STAT- MEDLINE
DA  - 20170309
DCOM- 20170317
LR  - 20170317
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 66
IP  - 9
DP  - 2017 Mar 10
TI  - CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence
      Syndrome.
PG  - 242-245
LID - 10.15585/mmwr.mm6609a2 [doi]
AB  - Neonatal abstinence syndrome (NAS) is a drug withdrawal syndrome that most
      commonly occurs in infants after in utero exposure to opioids, although other
      substances have also been associated with the syndrome (1). NAS usually appears
      within 48-72 hours of birth with a constellation of clinical signs, including
      central nervous system irritability (e.g., tremors), gastrointestinal dysfunction
      (e.g., feeding difficulties), and temperature instability (1) (Box 1). Opioid
      exposure during pregnancy might result from clinician-approved use of
      prescription opioids for pain relief; misuse or abuse of prescription opioids;
      illicit use (e.g., heroin); or medication-assisted treatment (MAT) of opioid use 
      disorder (2) (Box 2).
FAU - Ko, Jean Y
AU  - Ko JY
FAU - Wolicki, Sara
AU  - Wolicki S
FAU - Barfield, Wanda D
AU  - Barfield WD
FAU - Patrick, Stephen W
AU  - Patrick SW
FAU - Broussard, Cheryl S
AU  - Broussard CS
FAU - Yonkers, Kimberly A
AU  - Yonkers KA
FAU - Naimon, Rebecca
AU  - Naimon R
FAU - Iskander, John
AU  - Iskander J
LA  - eng
PT  - Journal Article
DEP - 20170310
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
SB  - IM
MH  - Centers for Disease Control and Prevention (U.S.)
MH  - Cost of Illness
MH  - Female
MH  - Health Knowledge, Attitudes, Practice
MH  - Humans
MH  - Infant, Newborn
MH  - Legislation as Topic
MH  - Neonatal Abstinence Syndrome/epidemiology/*prevention & control
MH  - Opioid-Related Disorders/epidemiology/prevention & control
MH  - Pregnancy
MH  - Prenatal Exposure Delayed Effects
MH  - *Public Health Practice
MH  - United States/epidemiology
EDAT- 2017/03/10 06:00
MHDA- 2017/03/18 06:00
CRDT- 2017/03/10 06:00
AID - 10.15585/mmwr.mm6609a2 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2017 Mar 10;66(9):242-245. doi:
      10.15585/mmwr.mm6609a2.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>